Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Understanding the biological mechanisms regulating circadian secretion of GLP-1
EF 2014-15
Résumé
GLP-1 is a gut peptide that acts as a fundamental link between nutrient ingestion and release of insulin which enhances nutrient disposal into peripheral tissues. GLP-1 is secreted from the intestinal L cell in response to circulating carbohydrates and fat thereby stimulating glucose-dependent insulin secretion. There is new evidence to suggest that the L cell is under circadian regulation, making it a key link in the newly described 'metabolic clock' which coordinates the peripheral metabolic responses to nutrient ingestion. The proposed project will therefore focus on developing our understanding of the biological mechanisms that are regulating circadian secretion of GLP-1. More specifically, the focus will be on studying pro- and anti-inflammatory mediators tumour necrosis factor alpha (TNFa) and interleukin-6 (IL-6) respectively. In vitro studies will be conducted in order to determine the rhythm in GLP-1 responses to these inflammatory mediators. Furthermore, in vivo studies on rats will be conducted by increasing TNFa through a high-fat diet and increasing IL-6 by subjecting rats to exercise. We expect that an increase in TNFa will disrupt the known circadian rhythm of GLP-1 release. On the other hand, we expect an increase in IL-6 will have the opposing effects of GLP-1 and serve to enhance and be able to normalize a disrupted circadian rhythm of GLP-1 release. In conclusion, this study will enhance our understanding of the control of secretion of the anti-diabetic hormone GLP-1. Furthermore, it will establish a novel pathway by which exercise through increasing GLP-1 release can improve metabolic control in obese patients with type II diabetes.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
331410
Name
Martchenko Alexandre
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding the biological mechanisms regulating circadian secretion of GLP-1
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Circadian Rhythm; Diabetes; Exercise; Glucagon-Like Peptide 1 (Glp-1); Inflammatory Mediators; Insulin; Intestinal Hormones; L Cell; Metabolic Clock; Obesity
Abstract
GLP-1 is a gut peptide that acts as a fundamental link between nutrient ingestion and release of insulin which enhances nutrient disposal into peripheral tissues. GLP-1 is secreted from the intestinal L cell in response to circulating carbohydrates and fat thereby stimulating glucose-dependent insulin secretion. There is new evidence to suggest that the L cell is under circadian regulation, making it a key link in the newly described 'metabolic clock' which coordinates the peripheral metabolic responses to nutrient ingestion. The proposed project will therefore focus on developing our understanding of the biological mechanisms that are regulating circadian secretion of GLP-1. More specifically, the focus will be on studying pro- and anti-inflammatory mediators tumour necrosis factor alpha (TNFa) and interleukin-6 (IL-6) respectively. In vitro studies will be conducted in order to determine the rhythm in GLP-1 responses to these inflammatory mediators. Furthermore, in vivo studies on rats will be conducted by increasing TNFa through a high-fat diet and increasing IL-6 by subjecting rats to exercise. We expect that an increase in TNFa will disrupt the known circadian rhythm of GLP-1 release. On the other hand, we expect an increase in IL-6 will have the opposing effects of GLP-1 and serve to enhance and be able to normalize a disrupted circadian rhythm of GLP-1 release. In conclusion, this study will enhance our understanding of the control of secretion of the anti-diabetic hormone GLP-1. Furthermore, it will establish a novel pathway by which exercise through increasing GLP-1 release can improve metabolic control in obese patients with type II diabetes.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Martchenko, Alexandre
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~